The Oxford Science Park

Find Out The Latest

You can keep in touch with exciting developments for The Oxford Science Park and its occupiers here.

You can also keep up to date by following us on Twitter or LinkedIn

British Bakels wins TOSP's 2023 Innovation Award

12 Jun 2023

Congratulations to British Bakels, winner of The Oxford Science Park's 2023 Innovation Award, part of Oxfordshire Business Awards Starting up in 1947, British Bakels produces a wide range of over 500 dry and wet bakery ingredients for the commercial bakery market and employs over 200 people. We were impressed by its entry focused on the development of near-infrared spectroscopy as part of production processes for their wet products.... Read more

OXFORD NANOPORE TECHNOLOGIES PLC - National German rare disease study

12 Jun 2023

National German rare disease study Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore"), the company delivering a new generation of nanopore-based molecular sensing technology, today announces a research collaboration agreement with the 'Clinical Long-read Genome Initiative' (lonGER), a new national German programme developed to evaluate the clinical and research applications of comprehensive nanopore-based sequencing to advance... Read more

Oxfordshire plays a pivotal role in UK’s ambition to be a scientific superpower according to a new report by Advanced Oxford

07 Jun 2023

Oxfordshire plays a pivotal role in UK’s ambition to be a scientific superpower according to a new report by Advanced Oxford Business leaders and academics alike have welcomed an insightful new report and interactive dashboard published by Advanced Oxford in conjunction with Elsevier. Oxfordshire’s Innovation Engine 2023 report assesses the growth of the region’s science and technology ecosystem over the last 10 years, the challenges ahead... Read more

Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Society of Clinical Oncology Meeti

02 Jun 2023

Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Society of Clinical Oncology Meeting Scancell Holdings plc ("Scancell" or the "Company") Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Society of Clinical Oncology Meeting ModiFY trial progressing through monotherapy expansion cohorts and combination... Read more

Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors

17 May 2023

OXFORD, England--(BUSINESS WIRE)--Ochre Bio, an innovator in chronic liver disease medicine development, today announced the appointment of Eliot Forster, Ph.D. as Chairperson of the Board of Directors. With decades of experience in pharmaceutical and biotechnology industries, cofounding and leading several companies Dr. Forster has successfully raised more than $550M in equity financing, having previously served as CEO at F-Star Therapeutics... Read more

News